6-122796917-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_006714.5(SMPDL3A):āc.420T>Gā(p.Phe140Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000775 in 1,613,594 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006714.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMPDL3A | NM_006714.5 | c.420T>G | p.Phe140Leu | missense_variant | 3/8 | ENST00000368440.5 | NP_006705.1 | |
SMPDL3A | NM_001286138.2 | c.27T>G | p.Phe9Leu | missense_variant | 2/7 | NP_001273067.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMPDL3A | ENST00000368440.5 | c.420T>G | p.Phe140Leu | missense_variant | 3/8 | 1 | NM_006714.5 | ENSP00000357425.4 | ||
SMPDL3A | ENST00000539041.5 | c.27T>G | p.Phe9Leu | missense_variant | 2/7 | 2 | ENSP00000442152.1 | |||
SMPDL3A | ENST00000487215.1 | n.475T>G | non_coding_transcript_exon_variant | 3/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152218Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000518 AC: 13AN: 251184Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135754
GnomAD4 exome AF: 0.0000780 AC: 114AN: 1461376Hom.: 0 Cov.: 30 AF XY: 0.0000825 AC XY: 60AN XY: 727024
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74376
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 17, 2024 | The c.420T>G (p.F140L) alteration is located in exon 3 (coding exon 3) of the SMPDL3A gene. This alteration results from a T to G substitution at nucleotide position 420, causing the phenylalanine (F) at amino acid position 140 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at